Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-021-03043-x
Abstract: Venetoclax treatment has demonstrated efficacy and a safety profile in chronic lymphocytic leukemia (CLL) patients, however the emergence of resistant cells is a current complication. We and others, previously reported that the activation of CLL… read more here.
Keywords: phenotype; resistant cll; cll; venetoclax ... See more keywords
Ibrutinib-resistant CLL: unwanted and unwonted!
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood-2017-01-761536
Abstract: In this issue of Blood, Ahn et al find intriguing clinical and molecular differences between early and late relapsing patients in a phase 2 trial of chronic lymphocytic leukemia (CLL) treated with ibrutinib.1 read more here.
Keywords: resistant cll; cll; ibrutinib resistant; unwanted unwonted ... See more keywords